Former cruiserweight champion Krzysztof Glowacki authored one of my 2023 Knockouts of the Year in his mixed martial arts debut, but the prognosis for his boxing career is much grimmer, as this morning saw UKAD announce a four-year suspension for failing a drug test.
Per the announcement, Glowacki (32-4, 20 KO) tested positive for the anabolic steroid boldenone after last January’s loss to Richard Riakporhe. A lengthy arbitration process ensued, with the National Anti-Doping Panel ultimately issuing the suspension in November.
Said suspension is backdated to April, when Glowacki first received word of the adverse finding.
Frankly, this might be a good outcome for Glowacki’s health. The 37-year-old has been violently stopped in three of his last four fights, and though there’s no shame in losing to the likes of Mairis Briedis, Lawrence Okolie, and the aforementioned Riakporhe, he’s clearly well below what he was during the WBSS days. I’d much rather see further MMA shenanigans in KSW.